(Q41085075)

26 September 2017

CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type (English)

1 reference

extranodal NK/T-cell lymphoma, nasal type

26 September 2017

0 references

author name string

Liang Wang

1

1 reference

26 September 2017

Hua Wang

2

1 reference

26 September 2017

Peng-fei Li

3

1 reference

26 September 2017

Yue Lu

4

1 reference

26 September 2017

Zhong-jun Xia

5

1 reference

26 September 2017

Hui-qiang Huang

6

1 reference

26 September 2017

Yu-jing Zhang

7

1 reference

26 September 2017

14 April 2015

1 reference

26 September 2017

1 reference

26 September 2017

94

1 reference

26 September 2017

8

1 reference

26 September 2017

1381-1388

1 reference

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

26 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Selective apoptosis of natural killer-cell tumours by l-asparaginase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Human CD38: a glycoprotein in search of a function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

The CD38 ectoenzyme family: advances in basic science and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Elotuzumab and daratumumab: emerging new monoclonal antibodies for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Clinical significance of serum soluble interleukin-2 receptor-α in extranodal natural killer/T-cell lymphoma (ENKTL): a predictive biomarker for treatment efficacy and valuable prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Hepatitis B virus infection correlates with poor prognosis of extranodal natural killer/T cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

CD38 and CD157: biological observations to clinical therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Expression of ezrin correlates with poor prognosis of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-015-2359-2

10.1007/S00277-015-2359-2

21 January 2018

Identifiers

DOI

1 reference

26 September 2017

1 reference